Mechanisms underlying the antidepressant response and treatment resistance

Frontiers in Behavioral Neuroscience

Volumn 8, Issue JUNE, 2014, Pages

  Levinstein, Marjorie R ^a   Samuels, Benjamin A ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Antidepressants; Depression; Mood; Mouse models; SSRI; Treatment resistance

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; KETAMINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANTIDEPRESSANT ACTIVITY; ANXIETY; BRAIN DEPTH STIMULATION; CHRONIC DRUG ADMINISTRATION; CHRONIC MILD STRESS; CHRONIC STRESS; CONNECTOME; DENTATE GYRUS; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG TARGETING; ELECTROCONVULSIVE THERAPY; EXPERIMENTAL MOUSE; GENE MUTATION; GENETIC POLYMORPHISM; HIPPOCAMPUS; HOMOZYGOSITY; HUMAN; LIPID DIET; NEUROMODULATION; NONHUMAN; PATHOGENESIS; PSYCHOTHERAPY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL BEHAVIOR; SOCIAL DEFEAT; TRANSCRANIAL MAGNETIC STIMULATION; TRANSGENIC MOUSE; TREATMENT RESISTANT DEPRESSION; VAGUS NERVE STIMULATION;

EID: 84903460460     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00208     Document Type: Review

References (132)

1. Aan Het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., et al. (2010). Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol. Psychiatry 67, 139-145. doi: 10.1016/j.biopsych.2009.08.038
2. Adhikari, A., Topiwala, M. A., and Gordon, J. A. (2010). Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety. Neuron 65, 257-269. doi: 10.1016/j.neuron.2009.12.002
3. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edn (DSM-5). Washington, DC: American Psychiatric Publishing.
4. Ardayfio, P., and Kim, K.-S. (2006). Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice. Behav. Neurosci. 120, 249-256. doi: 10.1037/0735-7044.120.2.249
5. Artigas, F., Romero, L., De Montigny, C., and Blier, P. (1996). Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Tr e n d s N e u r o s c i. 19, 378-383. doi: 10.1016/S0166-2236(96)10037-0
6. Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P. F., et al. (2011). NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91-95. doi: 10.1038/nature10130
7. Avery, D. H., Holtzheimer, P. E., Fawaz, W., Russo, J., Neumaier, J., Dunner, D. L., et al. (2006). A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol. Psychiatry 59, 187-194. doi: 10.1016/j.biopsych.2005.07.003
8. Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., et al. (2010). Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J. Clin. Psychopharmacol. 30, 273-281. doi: 10.1097/JCP.0b013e3181db8831
9. Bergman, S. A. (1999). Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth. Prog. 46, 10-20.
10. Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., et al. (2000). Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351-354. doi: 10.1016/S0006-3223(99)00230-9
11. Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., et al. (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol. Psychiatry 67, 110-116. doi: 10.1016/j.biopsych.2009.09.013
12. Bisgaard, C. F., Jayatissa, M. N., Enghild, J. J., Sanchéz, C., Artemychyn, R., and Wiborg, O. (2007). Proteomic investigation of the ventral rat hippocampus links DRP-2 to escitalopram treatment resistance and SNAP to stress resilience in the chronic mild stress model of depression. J. Mol. Neurosci. 32, 132-144. doi: 10.1007/s12031-007-0025-4
13. Blier, P., Piñeyro, G., El Mansari, M., Bergeron, R., and De Montigny, C. (1998). Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotrans-mission. Ann. N. Y. Acad. Sci. 861, 204-216.
14. Bueller, J. A., Aftab, M., Sen, S., Gomez-Hassan, D., Burmeister, M., and Zubieta, J. K. (2006). BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol. Psychiatry 59, 812-815. doi: 10.1016/j.biopsych.2005.09.022
15. Cameron, H. A., and Gould, E. (1994). Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 61, 203-209. doi: 10.1016/0306-4522(94)90224-0
16. Cameron, H. A., Tanapat, P., and Gould, E. (1998). Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway. Neuroscience 82, 349-354. doi: 10.1016/S0306-4522(97)00303-5
17. Cao, J. L., Covington, H. E., Friedman, A. K., Wilkinson, M. B., Walsh, J. J., Cooper, D. C., et al. (2010). Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. J. Neurosci. 30, 16453-16458. doi: 10.1523/JNEUROSCI.3177-10.2010
18. Carola, V., and Gross, C. (2012). Mouse Models of the 5-HTTLPR x Stress Risk Factor for Depression. Curr. Top. Behav. Neurosci. 12, 59-72. doi: 10.1007/7854_2011_190
19. Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al. (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389. doi: 10.1126/science.1083968
20. Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., et al. (2013). Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493, 532-536. doi: 10.1038/nature11713
21. Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., et al. (2006). Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314, 140-143. doi: 10.1126/science.1129663
22. Czéh, B., Michaelis, T., Watanabe, T., Frahm, J., De Biurrun, G., Van Kampen, M., et al. (2001). Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. U.S.A. 98, 12796-12801. doi: 10.1073/pnas.211427898
23. Czéh, B., Welt, T., Fischer, A. K., Erhardt, A., Schmitt, W., Müller, M. B., et al. (2002). Chronic psychosocial stress and concomitant repetitive tran-scranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol. Psychiatry 52, 1057-1065. doi: 10.1016/S0006-3223(02)01457-9
24. David, D. J., Samuels, B. A., Rainer, Q., Wang, J.-W., Marsteller, D., Mendez, I., et al. (2009). Neurogenesis-dependent and -independent effects of fluox-etine in an animal model of anxiety/depression. Neuron 62, 479-493. doi: 10.1016/j.neuron.2009.04.017
25. Dow, A. L., Russell, D. S., and Duman, R. S. (2005). Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: effects in behavioral models. J. Neurosci. 25, 4908-4916. doi: 10.1523/JNEUROSCI.5155-04.2005
26. Dranovsky, A., and Hen, R. (2006). Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiatry 59, 1136-1143. doi: 10.1016/j.biopsych.2006.03.082
27. Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269. doi: 10.1016/S0092-8674(03)00035-7
28. Gardier, A. M., Malagié, I., Trillat, A. C., Jacquot, C., and Artigas, F. (1996). Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antide-pressant drugs: recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 10, 16-27. doi: 10.1111/j.1472-8206.1996.tb00145.x
29. Gorman, J. M. (1996). Comorbid depression and anxiety spectrum disorders. Depress. Anxiety 4, 160-168.
30. Goto, Y., and O'Donnell, P. (2001). Synchronous activity in the hippocampus and nucleus accumbens in vivo. J. Neurosci. 21:RC131.
31. Gould, E., Cameron, H. A., Daniels, D. C., Woolley, C. S., and McEwen, B. S. (1992). Adrenal hormones suppress cell division in the adult rat dentate gyrus. J. Neurosci. 12, 3642-3650.
32. Gould, E., McEwen, B. S., Tanapat, P., Galea, L. A., and Fuchs, E. (1997). Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J. Neurosci. 17, 2492-2498.
33. Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., and Fuchs, E. (1998). Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc. Natl. Acad. Sci. U.S.A. 95, 3168-3171. doi: 10.1073/pnas.95.6.3168
34. Gould, E., Woolley, C. S., and McEwen, B. S. (1990). Short-term glucocorticoid manipulations affect neuronal morphology and survival in the adult dentate gyrus. Neuroscience 37, 367-375. doi: 10.1016/0306-4522(90)90407-U
35. Gourley, S. L., Kiraly, D. D., Howell, J. L., Olausson, P., and Taylor, J. R. (2008a). Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol. Psychiatry 64, 884-890. doi: 10.1016/j.biopsych.2008.06.016
36. Gourley, S. L., Wu, F. J., Kiraly, D. D., Ploski, J. E., Kedves, A. T., Duman, R. S., et al. (2008b). Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol. Psychiatry 63, 353-359. doi: 10.1016/j.biopsych.2007.07.016
37. Gourley, S. L., Wu, F. J., and Taylor, J. R. (2008c). Corticosterone regulates pERK1/2 map kinase in a chronic depression model. Ann. N. Y. Acad. Sci. 1148, 509-514. doi: 10.1196/annals.1410.076
38. Hariri, A. R., Goldberg, T. E., Mattay, V. S., Kolachana, B. S., Callicott, J. H., Egan, M. F., et al. (2003). Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23, 6690-6694.
39. Herman, J. P., and Mueller, N. K. (2006). Role of the ventral subiculum in stress integration. Behav. Brain Res. 174, 215-224. doi: 10.1016/j.bbr.2006.05.035
40. Hill, M. N., Hellemans, K. G., Verma, P., Gorzalka, B. B., and Weinberg, J. (2012). Neurobiology of chronic mild stress: parallels to major depression. Neurosci. Biobehav. Rev. 36, 2085-2117. doi: 10.1016/j.neubiorev.2012.07.001
41. Holmes, A., Yang, R. J., Murphy, D. L., and Crawley, J. N. (2002). Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27, 914-923. doi: 10.1016/S0893-133X(02)00374-3
42. Holtzheimer, P. E., and Mayberg, H. S. (2011a). Deep brain stimulation for psychiatric disorders. Annu. Rev. Neurosci. 34, 289-307. doi: 10.1146/annurev-neuro-061010-113638
43. Holtzheimer, P. E., and Mayberg, H. S. (2011b). Stuck in a rut: rethinking depression and its treatment. Tr e n d s N e u r o s c i. 34, 1-9. doi: 10.1016/j.tins.2010.10.004
44. Ibarguen-Vargas, Y., Surget, A., Touma, C., Palme, R., and Belzung, C. (2008). Multifaceted strain-specific effects in a mouse model of depression and of antidepressant reversal. Psychoneuroendocrinology 33, 1357-1368. doi: 10.1016/j.psyneuen.2008.07.010
45. Isingrini, E., Camus, V., Le Guisquet, A.-M., Pingaud, M., Devers, S., and Belzung, C. (2010). Association between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in mice. PLoS ONE 5:e10404. doi: 10.1371/journal.pone.0010404
46. Jankord, R., and Herman, J. P. (2008). Limbic regulation of hypothalamo-pituitary-adrenocortical function during acute and chronic stress. Ann. N. Y. Acad. Sci. 1148, 64-73. doi: 10.1196/annals.1410.012
47. Jayatissa, M. N., Bisgaard, C., Tingström, A., Papp, M., and Wiborg, O. (2006). Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression. Neuropsychopharmacology 31, 2395-2404. doi: 10.1038/sj.npp.1301041
48. Jimenez, F., Velasco, F., Salin-Pascual, R., Hernandez, J. A., Velasco, M., Criales, J. L., et al. (2005). A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery 57, 585-593. discussion: 585-593. doi: 10.1227/01.NEU.0000170434.44335.19
49. Karishma, K. K., and Herbert, J. (2002). Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16, 445-453. doi: 10.1046/j.1460-9568.2002.02099.x
50. Katz, R. J. (1982). Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol. Biochem. Behav. 16, 965-968. doi: 10.1016/0091-3057(82)90053-3
51. Kennedy, S. H., Giacobbe, P., Rizvi, S. J., Placenza, F. M., Nishikawa, Y., Mayberg, H. S., et al. (2011). Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am. J. Psychiatry 168, 502-510. doi: 10.1176/appi.ajp.2010.10081187
52. Kessler, R. C. (2009). The costs of depression. Psychiatr. Clin. North Am. 35, 1-14. doi: 10.1016/j.psc.2011.11.005
53. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., et al. (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095-3105. doi: 10.1001/jama.289.23.3095
54. Kheirbek, M. A., Drew, L. J., Burghardt, N. S., Costantini, D. O., Tannenholz, L., Ahmari, S. E., et al. (2013). Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus. Neuron 77, 955-968. doi: 10.1016/j.neuron.2012.12.038
55. Kocabas, N. A., Antonijevic, I., Faghel, C., Forray, C., Kasper, S., Lecrubier, Y., et al. (2011). Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder. Int. Clin. Psychopharmacol. 26, 1-10. doi: 10.1097/YIC.0b013e32833d18f8
56. Kreiner, G., Chmielarz, P., Roman, A., and Nalepa, I. (2013). Gender differences in genetic mouse models evaluated for depressive-like and antidepressant behavior. Pharmacol. Rep. 65, 1580-1590. doi: 10.1016/S1734-1140(13)71519-6
57. Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., et al. (2007). Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131, 391-404. doi: 10.1016/j.cell.2007.09.018
58. Krystal, J. H., Sanacora, G., and Duman, R. S. (2013). Rapid-acting glutamater-gic antidepressants: the path to ketamine and beyond. Biol. Psychiatry 73, 1133-1141. doi: 10.1016/j.biopsych.2013.03.026
59. Layer, R. T., Popik, P., Olds, T., and Skolnick, P. (1995). Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol. Biochem. Behav. 52, 621-627. doi: 10.1016/0091-3057(95)00155-P
60. Le François, B., Czesak, M., Steubl, D., and Albert, P. R. (2008). Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55, 977-985. doi: 10.1016/j.neuropharm.2008.06.046
61. Lemonde, S., Turecki, G., Bakish, D., Du, L., Hrdina, P. D., Bown, C. D., et al. (2003). Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J. Neurosci. 23, 8788-8799.
62. Leonardo, E. D., and Hen, R. (2006). Genetics of affective and anxiety disorders. Annu. Rev. Psychol. 57, 117-137. doi: 10.1146/annurev.psych.57.102904.190118
63. Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531. doi: 10.1126/science.274.5292.1527
64. Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., et al. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959-964. doi: 10.1126/science.1190287
65. Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., et al. (2011). Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol. Psychiatry 69, 754-761. doi: 10.1016/j.biopsych.2010.12.015
66. Lira, A., Zhou, M., Castanon, N., Ansorge, M. S., Gordon, J. A., Francis, J. H., et al. (2003). Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54, 960-971. doi: 10.1016/S0006-3223(03)00696-6
67. Lohoff, F. W. (2010). Overview of the genetics of major depressive disorder. Curr. Psychiatry Rep. 12, 539-546. doi: 10.1007/s11920-010-0150-6
68. Lopez-Leon, S., Janssens, A. C., Gonzalez-Zuloeta Ladd, A. M., Del-Favero, J., Claes, S. J., Oostra, B. A., et al. (2008). Meta-analyses of genetic studies on major depressive disorder. Mol. Psychiatry 13, 772-785. doi: 10.1038/sj.mp.4002088
69. Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., and Kennedy, S. H. (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol. Psychiatry 64, 461-467. doi: 10.1016/j.biopsych.2008.05.034
70. Lucas, G., Rymar, V. V., Du, J., Mnie-Filali, O., Bisgaard, C., Manta, S., et al. (2007). Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55, 712-725. doi: 10.1016/j.neuron.2007. 07.041
71. Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., et al. (2008). Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol. Psychiatry 63, 349-352. doi: 10.1016/j.biopsych.2007.05.028
72. Malone, D. A. Jr., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., et al. (2009). Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol. Psychiatry 65, 267-275. doi: 10.1016/j.biopsych.2008.08.029
73. Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., et al. (2005). Deep brain stimulation for treatment-resistant depression. Neuron 45, 651-660. doi: 10.1016/j.neuron.2005.02.014
74. McEwen, B. S. (1999). Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22, 105-122. doi: 10.1146/annurev.neuro.22.1.105
75. McEwen, B. S., Albeck, D., Cameron, H., Chao, H. M., Gould, E., Hastings, N., et al. (1995). Stress and the brain: a paradoxical role for adrenal steroids. Vitam. Horm. 51, 371-402. doi: 10.1016/S0083-6729(08)61045-6
76. McEwen, B. S., Weiss, J. M., and Schwartz, L. S. (1968). Selective retention of corticosterone by limbic structures in rat brain. Nature 220, 911-912. doi: 10.1038/220911a0
77. Meloni, D., Gambarana, C., De Montis, M. G., Dal Pra, P., Taddei, I., and Tagliamonte, A. (1993). Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats. Pharmacol. Biochem. Behav. 46, 423-426. doi: 10.1016/0091-3057(93)90374-3
78. Mendez-David, I., David, D. J., Darcet, F., Wu, M. V., Kerdine-Romer, S., Gardier, A. M., et al. (2013a). Rapid Anxiolytic effects of a 5-HT receptor agonist are mediated by a neurogenesis-independent mechanism. Neuropsychopharmacology 39, 1366-1378. doi: 10.1038/npp.2013.332
79. Mendez-David, I., El-Ali, Z., Hen, R., Falissard, B., Corruble, E., Gardier, A. M., et al. (2013b). A method for biomarker measurements in peripheral blood mononuclear cells isolated from anxious and depressed mice: beta-arrestin 1 protein levels in depression and treatment. Front. Pharmacol. 4:124. doi: 10.3389/fphar.2013.00124
80. Merkl, A., Heuser, I., and Bajbouj, M. (2009). Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations. Exp. Neurol. 219, 20-26. doi: 10.1016/j.expneurol.2009.04.027
81. Mineur, Y. S., Belzung, C., and Crusio, W. E. (2006). Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav. Brain Res. 175, 43-50. doi: 10.1016/j.bbr.2006.07.029
82. Moryl, E., Danysz, W., and Quack, G. (1993). Potential antidepressive properties of amantadine, memantine and bifemelane. Pharmacol. Toxicol. 72, 394-397. doi: 10.1111/j.1600-0773.1993.tb01351.x
83. Munafo, M. R., Freimer, N. B., Ng, W., Ophoff, R., Veijola, J., Miettunen, J., et al. (2009). 5-HTTLPR genotype and anxiety-related personality traits: a meta-analysis and new data. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 271-281. doi: 10.1002/ajmg.b.30808
84. Murphy, D. L., Lerner, A., Rudnick, G., and Lesch, K. P. (2004). Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol. Interv. 4, 109-123. doi: 10.1124/mi.4.2.8
85. Murray, F., Smith, D. W., and Hutson, P. H. (2008). Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur. J. Pharmacol. 583, 115-127. doi: 10.1016/j.ejphar.2008.01.014
86. Nestler, E. J., Barrot, M., Dileone, R. J., Eisch, A. J., Gold, S. J., and Monteggia, L. M. (2002). Neurobiology of depression. Neuron 34, 13-25. doi: 10.1016/S0896-6273(02)00653-0
87. Nestler, E. J., and Carlezon, W. A. Jr. (2006). The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 59, 1151-1159. doi: 10.1016/j.biopsych.2005.09.018
88. Papp, M., and Moryl, E. (1994). Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression. Eur. J. Pharmacol. 263, 1-7. doi: 10.1016/0014-2999(94) 90516-9
89. Parsey, R. V., Olvet, D. M., Oquendo, M. A., Huang, Y.-Y., Ogden, R. T., and Mann, J. J. (2006). Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31, 1745-1749. doi: 10.1038/sj.npp.1300992
90. Perlmutter, J. S., and Mink, J. W. (2006). Deep brain stimulation. Annu. Rev. Neurosci. 29, 229-257. doi: 10.1146/annurev.neuro.29.051605.112824
91. Przegalinski, E., Tatarczynska, E., Deren-Wesolek, A., and Chojnacka-Wojcik, E. (1997). Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist. Neuropharmacology 36, 31-37. doi: 10.1016/S0028-3908(96) 00157-8
92. Rainer, Q., Xia, L., Guilloux, J. P., Gabriel, C., Mocaer, E., Hen, R., et al. (2012). Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. Int. J. Neuropsychopharmacol. 15, 321-335. doi: 10.1017/S1461145711000356
93. Richardson-Jones, J. W., Craige, C. P., Guiard, B. P., Stephen, A., Metzger, K. L., Kung, H. F., et al. (2010). 5-HT(1A) autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65, 40-52. doi: 10.1016/j.neuron.2009.12.003
94. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., et al. (2006a). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905-1917. doi: 10.1176/appi.ajp.163.11.1905
95. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., et al. (2006b). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. 354, 1231-1242. doi: 10.1056/NEJMoa052963
96. Samuels, B. A., and Hen, R. (2011). Neurogenesis and affective disorders. Eur. J. Neurosci. 33, 1152-1159. doi: 10.1111/j.1460-9568.2011.07614.x
97. Samuels, B. A., Leonardo, E. D., Dranovsky, A., Williams, A., Wong, E., Nesbitt, A. M., et al. (2014). Global state measures of the dentate gyrus gene expression system predict antidepressant-sensitive behaviors. PLoS ONE 9:e85136. doi: 10.1371/journal.pone.0085136
98. Samuels, B. A., Leonardo, E. D., Gadient, R., Williams, A., Zhou, J., David, D. J., et al. (2011). Modeling treatment-resistant depression. Neuropharmacology 61, 408-413. doi: 10.1016/j.neuropharm.2011.02.017
99. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809. doi: 10.1126/science.1083328
100. Sartorius, A., and Henn, F. A. (2007). Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med. Hypotheses 69, 1305-1308. doi: 10.1016/j.mehy.2007.03.021
101. Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., et al. (2008). Deep brain stimulation to reward circuitry alleviates anhedo-nia in refractory major depression. Neuropsychopharmacology 33, 368-377. doi: 10.1038/sj.npp.1301408
102. Schweizer, M. C., Henniger, M. S., and Sillaber, I. (2009). Chronic mild stress (CMS) in mice: of anhedonia, 'anomalous anxiolysis' and activity. PLoS ONE 4:e4326. doi: 10.1371/journal.pone.0004326
103. Shimizu, E., Hashimoto, K., and Iyo, M. (2004). Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am. J. Med. Genet. B Neuropsychiatr. Genet. 126B, 122-123. doi: 10.1002/ajmg.b.20118
104. Shirayama, Y., Chen, A. C., Nakagawa, S., Russell, D. S., and Duman, R. S. (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 3251-3261.
105. Sloviter, R. S., Valiquette, G., Abrams, G. M., Ronk, E. C., Sollas, A. L., Paul, L. A., et al. (1989). Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science 243, 535-538. doi: 10.1126/science. 2911756
106. Surget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., et al. (2008). Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol. Psychiatry 64, 293-301. doi: 10.1016/j.biopsych.2008.02.022
107. Surget, A., Tanti, A., Leonardo, E. D., Laugeray, A., Rainer, Q., Touma, C., et al. (2011). Antidepressants recruit new neurons to improve stress response regulation. Mol. Psychiatry 16, 1177-1188. doi: 10.1038/mp.2011.48
108. Szeszko, P. R., Lipsky, R., Mentschel, C., Robinson, D., Gunduz-Bruce, H., Sevy, S., et al. (2005). Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol. Psychiatry 10, 631-636. doi: 10.1038/sj.mp.4001656
109. Taylor, M. J., Sen, S., and Bhagwagar, Z. (2010). Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol. Psychiatry 68, 536-543. doi: 10.1016/j.biopsych.2010.04.034
110. Triarhou, L. C. (2008). Centenary of Christfried Jakob's discovery of the visceral brain: an unheeded precedence in affective neuroscience. Neurosci. Biobehav. Rev. 32, 984-1000. doi: 10.1016/j.neubiorev.2008.03.013
111. Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., et al. (2006a). Medication augmentation after the failure of SSRIs for depression. N. Engl. J. Med. 354, 1243-1252. doi: 10.1056/NEJMoa 052964
112. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., et al. (2006b). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 163, 28-40. doi: 10.1176/appi.ajp.163.1.28
113. Trullas, R., and Skolnick, P. (1990). Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol. 185, 1-10. doi: 10.1016/0014-2999(90)90204-J
114. Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., and Nestler, E. J. (2006). Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9, 519-525. doi: 10.1038/nn1659
115. Vialou, V., Robison, A. J., Laplant, Q. C., Covington, H. E., Dietz, D. M., Ohnishi, Y. N., et al. (2010). DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat. Neurosci. 13, 745-752. doi: 10.1038/ nn.2551
116. *D Project results: a comprehensive review of findings. Curr. Psychiatry Rep. 9, 449-459. doi: 10.1007/s11920-007-0061-3
117. Wilkinson, M. B., Dias, C., Magida, J., Mazei-Robison, M., Lobo, M., Kennedy, P., et al. (2011). A novel role of the WNT-dishevelled-GSK3beta signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J. Neurosci. 31, 9084-9092. doi: 10.1523/JNEUROSCI.0039-11.2011
118. Wilkinson, M. B., Xiao, G., Kumar, A., Laplant, Q., Renthal, W., Sikder, D., et al. (2009). Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J. Neurosci. 29, 7820-7832. doi: 10.1523/JNEUROSCI.0932-09.2009
119. Willner, P. (1983). Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res. 287, 211-224. doi: 10.1016/0165-0173(83) 90005-X
120. Willner, P. (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90-110. doi: 10.1159/000087097
121. Willner, P., Muscat, R., and Papp, M. (1992). An animal model of anhedonia. Clin. Neuropharmacol. 15(Suppl. 1), Pt A, 550A-551A.
122. Willner, P., Towell, A., Sampson, D., Sophokleous, S., and Muscat, R. (1987). Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93, 358-364. doi: 10.1007/BF00187257
123. Witter, M. P., and Amaral, D. G. (2004). "Chapter 21: Hippocampal Formation," in The Rat Nervous System, ed G. Paxinos (San Diego, CA: Elsevier Academic Press), 635-704.
124. Wong, E. Y., and Herbert, J. (2004). The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus. Eur. J. Neurosci. 20, 2491-2498. doi: 10.1111/j.1460-9568.2004.03717.x
125. Wu, S., and Comings, D. E. (1999). A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr. Genet. 9, 105-106. doi: 10.1097/00041444-199906000-00010
126. Yalcin, I., Belzung, C., and Surget, A. (2008). Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey. Behav. Brain Res. 193, 140-143. doi: 10.1016/j.bbr.2008.04.021
127. Zacharko, R. M., and Anisman, H. (1991). Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci. Biobehav. Rev. 15, 391-405. doi: 10.1016/S0149-7634(05)80032-6
128. Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., et al. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63, 856-864. doi: 10.1001/archpsyc.63.8.856
129. Zarate, C., Duman, R. S., Liu, G., Sartori, S., Quiroz, J., and Murck, H. (2013). New paradigms for treatment-resistant depression. Ann. N. Y. Acad. Sci. 1292, 21-31. doi: 10.1111/nyas.12223
130. Zhao, Y., Ma, R., Shen, J., Su, H., Xing, D., and Du, L. (2008). A mouse model of depression induced by repeated corticosterone injections. Eur. J. Pharmacol. 581, 113-120. doi: 10.1016/j.ejphar.2007.12.005
131. Zou, Y. F., Wang, Y., Liu, P., Feng, X. L., Wang, B. Y., Zang, T. H., et al. (2010a). Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients. Neuropsychobiology 61, 71-78. doi: 10.1159/000265132
132. Zou, Y. F., Ye, D. Q., Feng, X. L., Su, H., Pan, F. M., and Liao, F. F. (2010b). Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder. Eur. Neuropsychopharmacol. 20, 535-544. doi: 10.1016/j.euroneuro.2009.12.005